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Summary
Background: Bronchial asthma is the most frequent chronic respiratory disease in both
adults and children. The prevalence and burden of asthma vary considerably between
different regions of the world. Information on asthma in Africa is fragmentary and
relatively old.
Objective: The objective of this cross-sectional epidemiological survey was to determine
the prevalence and burden of asthma in the North African countries of Algeria,
Morocco and Tunisia using the methodology developed in the Asthma Insights and Reality
(AIR) programme.
Methods: A general population sample was generated using a stratiﬁed sampling method
based on randomly-generated lists of telephone numbers. The target sample consisted
of 10 000 households in each country, which were contacted by telephone. A structured
interview was proposed. Two screening questions were asked to identify subjects with
asthma. Subjects who met these criteria were then questioned in more detail about their
asthma.
Results: Of 30 350 households contacted, 1 090 subjects with asthma were identiﬁed of
whom 872 provided complete data. The age- and gender-adjusted prevalence of asthma
was 3.45% [95%CI: 3.09 3.80%] in Algeria, 3.89% [95%CI: 3.52 4.27%] in Morocco and 3.53%
[95%CI: 3.18 3.89%] in Tunisia. Prevalence was highest in children and older adults, and
in urban areas. Annual incidence rates ranged between 28/10 000 in Tunisia and 46/10 000
in Algeria. 74.3% of adults reported being handicapped by their asthma all or most of the
time, 26.4% reported a visit to a hospital emergency department in the previous year and
23.9% absence from work or school due to asthma. 48.0% reported that their sleep was
very or quite disturbed by asthma.
Conclusions: The prevalence of asthma in the Maghreb countries is moderate, but its
impact is high.
© 2009 Published by Elsevier Ltd.
* Tel: +971 4 332 1070; fax: +971 4 332 3071.
E-mail address: abdelkader.a.el-hasnaoui@gsk.com (A. El Hasnaoui).
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Introduction
Bronchial asthma is the most frequent chronic respiratory
disease in both adults and children. A recent report 1 on the
global burden of asthma published by the Global Initiative
for Asthma (GINA) estimated that asthma affects around
300 million people in the world, with the number of
disability-adjusted life years lost due to asthma estimated
at around 15 million per year, and accounting for about
1 in every 250 deaths worldwide. The direct and indirect
medical costs associated with asthma are substantial.
In the early 1990s, two large international surveys
conducted in the general population described in detail
the prevalence and impact of asthma in adults and
children. These were the European Community Respiratory
Health Survey (ECRHS) 2, which evaluated adults, and the
International Survey of Asthma and Allergy in Children
(ISAAC) 3,4 studies. More recently, a series of surveys,
collectively constituting the Asthma Insights and Reality
(AIR) programme, have been performed in a number
of countries using a standardised protocol 5. As well as
collecting data on prevalence and burden, the AIR surveys
also collected data on asthma control as determined using
the GINA guidelines, on management and treatment, and
on perceptions and understanding of asthma. The different
AIR surveys were performed in the United States in 1998 6,
in Canada in 1999 7, in Western Europe in 1999 8, in the
Asia-Paciﬁc region 9 and in Japan 10 in 2000, in Central and
Eastern Europe in 2001 5, and in Latin America 11, Australia 12
and Turkey 13 in 2003 and in several Middle-East countries in
2007 14,15. The Japanese study was reiterated in 2005 16.
These surveys and others have revealed major differences
in the prevalence of asthma between different regions of
the globe, ranging from <2.5% in Eastern Asian countries
such as China and Indonesia to >10% in the British
Isles, Australia, Brazil and Canada 1. As well as these
regional differences, there is also evidence for temporal
changes in the prevalence of asthma, with an increase
in prevalence in both children 17 and adults 18,19 being
noted in many countries over the last three decades.
Although improved case ascertainment may contribute to
this increase, environmental factors such as urbanisation
and biological factors such as atopic sensitisation may also
be involved 20,21.
In many regions of the world, notably Africa, there is
a paucity of recent information on the epidemiology of
asthma. Concerning the Maghreb countries of North Africa,
one urban centre in Algeria (Algiers) and three in Morocco
(Rabat, Casablanca and Marrakech) participated in the
ISAAC survey in 1994 1995. In this survey, twelve-month
prevalence rates for wheeze in the 13 14 year old age group
were 7.8% in Algeria and 7.5% in Morocco 3. The ISAAC III
study also found that prevalence rates in Africa were around
twice as high in urban areas compared to rural areas. A
number of older studies conducted in the 1980s in individual
centres or regions of all three Maghreb countries identiﬁed
lower prevalence rates of paediatric asthma, ranging from
2% to 5% 22, although more recent studies revealed rates,
ranging from 8% to 10% 22, consistent with the ISAAC study. It
has been postulated that this marked increase in prevalence
may be due to ‘Westernisation’ of Maghreb society during
this period 22.
In adults, even less data is available. A study in the
Algiers region performed in 1986 reported an estimated
prevalence of respiratory symptoms among individuals aged
7 70 years of 2.3% 23. In 1990, Algiers participated in the
ECRH survey, and a prevalence for diagnosed asthma in
20 44 year olds of 3.0% percent was reported. This was
one of the lowest prevalence rates detected in any of the
countries participating in the ECRH survey 2. More recently,
a survey conducted in the Zeralda district of Algeria (coastal
plain) reported a cumulative prevalence of 1.8% in the
total population (all ages), although the authors pointed
out that the sampling method used did not ensure the
representativity of the study sample 24. To our knowledge,
there is no published data on the prevalence of asthma in
adults in either Morocco or Tunisia.
Given the pertinence of asthma as a public health issue
worldwide 1, it is important to collect reliable and up to
date information on the epidemiology of asthma in North
African countries. To this end, we have implemented a
large general population survey (AIRMAG) of the prevalence,
burden, management and control of asthma in the three
countries of the Maghreb using a comparable approach to
that used in the previous AIR surveys. This article describes
the methodology of the AIRMAG study and presents the
principle results obtained concerning the prevalence of
asthma and its impact in adults.
Methods
This was a cross-sectional epidemiological survey of asthma
conducted in a random sample of the general population
of Algeria, Morocco and Tunisia between January 2008 and
May 2008.
Study sample
A sample of the general population in each of the three
participating countries was generated using a random
stratiﬁed sampling method. A random list of landline or
mobile telephone numbers was constituted as an initial step
by generating random numbers in the format of telephone
numbers covering both ﬁxed and mobile telephone formats.
Given that the proportion of all possible telephone numbers
that was actually attributed differed between countries, it
was necessary to generate different sized sets of random
numbers (largest in Tunisia and smallest in Morocco) in order
to ensure meeting the target sample of attributed numbers.
Households were contacted by ringing each number in the
list consecutively. Each number was dialled up to ten times
in case of non-response before bring considered a contact
failure. In order to optimise chances of success, calls were
made on different days of the week, including week-ends
and at different times, including evenings. After ten calls,
outcomes were categorised as interview, formal refusal,
not a valid number (out of service, not a household, or no
response after ten calls).
Respondents were asked if they were willing to
participate in a questionnaire about health in general.
The process continued until a target sample of 10 000
individuals agreeing to participate in each country was
reached. Real-time stratiﬁcation was performed in order to
ensure representativity compared to the general population
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Table 1. Screening questions used to identify individuals with asthma
1. Have you had an asthma attack or asthma symptoms in the previous twelve months?
2. Have you taken medication for asthma attacks (eg pills, inhaled powders, aerosols etc) in the previous twelve months?
2a. Have you taken ventolin in the previous twelve months?
of each country, whereby interviewers were expected
to respect a ﬁxed quota of subjects fulﬁlling predeﬁned
sociodemographic criteria for a given stratum. A crossed
stratiﬁcation was used for ensuring representativity by
age and gender and a marginal stratiﬁcation for ensuring
representativity by region. The structure of the strata were
deﬁned using national population data obtained from the
African Development Bank Group 25 and the most recent
national census data.
The ﬁrst question of the interview referred to the
characterisation of the household structure (number in
family: members, gender and age). The household member
to answer the questionnaire was then selected randomly
by the CAPI. If this individual was present and available,
the interview was completed there and then. Otherwise,
an appointment was made for a subsequent time.
For the purposes of the analysis, the study population was
divided into an adult group (aged sixteen and over) and a
paediatric group (under sixteen years). For the paediatric
group, a parent answered the questionnaire on behalf of
the identiﬁed child.
Data collection
Telephone interviews were conducted by seventeen local
interviewers (seven for Tunisia, ﬁve for Morocco and ﬁve
for Algeria). The interviewers were students who had
been trained about asthma and the study protocol and on
telephone interview technique. Interviewers spoke French
and the local dialectal form of Arabic appropriate for
the region. Interviewees could choose the language in
which they chose to respond. Since certain berberophone
populations in the Maghreb may not feel comfortable
responding in Arabic, the interviewer could conduct the
telephone interview in French or in Berber language
if necessary. The CAPI (Computer Assisted Personal
Interview) method and CONVERSO® software (developed by
Conversoft® France) were used for the interview. Questions
in the interview were generally closed and the interviewers
were not required to interpret the replies given. The
interview lasted from ﬁfteen to ﬁfty minutes. No speciﬁc
gifts or incentives were offered to participating subjects.
Prior to initiating the survey, the questionnaires were
initially translated from French to local dialectal Arabic by
the local expert of each country. A feasibility study was
then performed to assess comprehension, acceptability and
relevance of the questionnaire. In this, the questionnaires
were administered to a general population sample in order
to estimate potential response rates and to ensure accept-
ability of health-related questionnaires and the language
proposed. Items that could potentially be ambiguous or
poorly understood were rephrased accordingly.
In a ﬁrst step, sociodemographic data was collected to
ensure that the respondent matched an open stratum. If
this was the case, two screening questions were asked to
identify subjects fulﬁlling diagnostic criteria for asthma
(Table 1). During the course of the study, a speciﬁer
for the second question was added (Question 2a) and
interviewees were speciﬁcally asked about use of short-
acting b-mimetics (ventolin has become a general term
for asthma relief medication in these countries). Subjects
responding positively to either of the questions were
considered as having asthma for the purposes of this study.
During a second step, subjects who met these criteria
were then questioned in more detail to collect information
on the frequency and severity of symptoms, impact on
activities of everyday life, treatments, monitoring, asthma
control and knowledge about asthma.
Asthma control was assessed in two ways. Firstly, the
Asthma Control Test (ACT) 26,27 was administered. This is a
questionnaire containing ﬁve items which can each be rated
on a ﬁve-point Likert scale. Since the ACT has only been
validated in patients aged over twelve, this questionnaire
was only proposed to subjects in the adult subpopulation.
The second assessment was based on the GINA criteria
for asthma control 28. Data relating to the GINA criteria
were extracted from the questionnaire and used to assign
subjects to one of three levels of control (controlled, partly
controlled and uncontrolled).
Severity was assessed using an adaptation of the
GINA-based severity score used in the previous AIR
studies 5. Brieﬂy, one of four clinical severity grades
(intermittent asthma, mild persistent asthma, moderate
persistent asthma and severe persistent asthma) was
assigned to each patient based on frequency of the
asthma symptoms. The original severity score contains ﬁve
items. However, data on the two last items (exercise-
induced symptoms and symptom frequency during a typical
week) were not collected in the AIRMAG study. The
overall severity grade assigned corresponded to the most
severe grade reported for any individual item. Subjects
reporting severe episodes every day over the previous years
were systematically assigned to the ‘severe persistent’
severity grade.
For certain interviewees, the interview was repeated
one week later in order to test the reproducibility of the
ACT. These data are presented in the article describing
the psychometric validation of the ACT elsewhere in this
supplement 29.
Statistical analysis
Crude prevalence rates were adjusted for age and gender
by weighting each subject to take into account the actual
structure of age and gender in the national population. Age-
and gender-speciﬁc prevalence rates are provided with their
95% conﬁdence intervals (CI). Adjusted prevalence rates
were determined for each region of the three participating
countries. This adjustment was necessary to take into
account the relative numbers of adults and children in each
country, since the adult subgroup was over-represented
compared to the paediatric subgroup.
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Numbers generated
N = 37 442
Households contacted
N = 19 133 (51.1%)
Subjects interviewed
N = 10 015 (52.3%)
Asthmaquestionnaires
N = 236 (2.4%)
Children
N = 82
Adults
N = 154
ALGERIA
Numbers generated
N = 27 330
Households contacted
N = 14 269 (52.2%)
Subjects interviewed
N = 10 051 (70.3%)
Asthmaquestionnaires
N = 310 (3.1%)
Children
N = 74
Adults
N = 236
MOROCCO
Numbers generated
N = 45 025
Households contacted
N = 13 587 (30.2%)
Subjects interviewed
N = 10 284 (75.7%)
Asthmaquestionnaires
N = 326 (3.2%)
Children
N = 92
Adults
N = 234
TUNISIA
Fig. 1. Structure of the study sample in the three participating countries. Percentages are calculated with respect to the previous box on the diagram
in each case.
Incidence rates were estimated from the proportion of
subjects completing the asthma questionnaire who reported
having received a diagnosis of asthma in the previous
twelve months. This proportion was then extrapolated
to the subjects fulﬁlling criteria for asthma with the
screening questionnaire who did not complete the asthma
questionnaire in order to generate the total number of
subjects in the sample who fulﬁlled criteria for asthma
and who had received a diagnosis within the past year.
This number was used to compute the estimated incidence
rate, which was adjusted for age and gender to reﬂect the
demographic structure of the general population in each of
the three countries.
Inter-group comparisons were performed with the c2
test or Fisher’s exact test for categorical variables and
Student’s t-test for continuous variables (corrected using
the Welch-Satterthwaite equation in case of heterogeneous
variance).
Two-sided tests were used throughout and a probability
level of p < 0.05 was considered signiﬁcant. All data were
controlled, validated and analysed centrally (Kappa Sante´,
Paris, France) using SAS software, version 9.1 (SAS Institute,
Cary, USA).
Results
Study population
The structure of the study sample is illustrated in Fig. 1.
In order to achieve the target sample size of 10 000
interviewees in each of the three participating countries, it
was necessary to dial a total of 109 797 telephone numbers,
of which 62 781 (67.2%) were not exploited (approximately
half the numbers in Algeria and Morocco and around two-
thirds in Tunisia). The principal reasons for this were number
not in service (from 4.9% in Morocco to 36.4% in Tunisia),
lack of reply after ten calls (from 11.2% in Tunisia to 21.7% in
Morocco), business addresses (from 3.3% in Algeria to 8.6% in
Morocco) and quota exceeded (5.1% in Algeria to 13.7% in
Tunisia). For the 47 016 numbers exploited, the respondent
refused to participate in the study in 16 666 cases (35.4%).
Refusal rates varied from 24.3% in Tunisia and 29.7% in
Morocco to 47.7% in Algeria. For the remainder, an interview
was proposed to a randomly selected household member,
thus generating the study sample of 30 350 subjects.
One thousand and ninety subjects interviewed fulﬁlled
the criteria for asthma in the screening questionnaire
and were proposed the opportunity to participate in
the second part of the study and to answer detailed
questions on asthma. Eight hundred and seventy-two
patients accepted (80.0%) and provided complete data.
Refusal rates were again lowest in Tunisia (11.7%) and
highest in Algeria (30.2%).
Prevalence of asthma in the general population
In the entire study sample, 1 090 subjects (3.6%) replied in
the afﬁrmative to one of the two screening questions and
were thus considered to have asthma. Of these subjects,
774 (71.0%) reported asthma symptoms or attacks in the
previous year and 849 (77.9%) reported use of asthma
medications. Only 34 subjects (3.1%) were identiﬁed only on
the basis of a positive reply to the speciﬁc question on use
of short-acting b-mimetics. The crude prevalence of asthma
was similar in the three Maghreb countries (3.4% in Algeria,
3.8% in Morocco and 3.6% in Tunisia).
The overall age- and gender-adjusted prevalence of
asthma was 3.45% [95%CI: 3.09 3.80%] in Algeria, 3.89%
[95%CI: 3.52 4.27%] in Morocco and 3.53% [95%CI: 3.18
3.89%] in Tunisia. Age- and gender-speciﬁc prevalence rates
are presented in Fig. 2. In Algeria, prevalence rates in
males and females were comparable, but large differences
were observed in the prevalence of asthma between age
groups, this being highest in children aged under sixteen
and in the oldest group (>54 years). In contrast, in Morocco,
prevalence was signiﬁcantly higher in females than in males,
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Fig. 2. Age- and gender-speciﬁc prevalence rates for asthma in three
participating countries with their 95% conﬁdence intervals.
but age differences were modest. The pattern observed for
Tunisia was intermediate between those seen in the other
two countries, with only the > 54 year age group showing a
markedly higher prevalence of asthma.
Some regional variation in asthma prevalence rates was
observed in all three countries (Fig. 3). In Algeria, the
highest rates were observed in the densely-populated
central coastal strip around Algiers and lowest in the desert
of the South. In Morocco, prevalence was again higher in the
densely-populated central coastal strip (Rabat, Casablanca)
than in the mountainous regions of the East and South,
although the highest rates of all were observed in the
Fig. 3. Regional age- and gender-adjusted prevalence rates for asthma in
three participating countries with their 95% conﬁdence intervals.
Saharan South. In Tunisia, prevalence was higher in the more
urbanised North than in the Saharan South.
During the interview, subjects were asked whether they
had ever received a diagnosis of asthma. This was the case
for 306 subjects in Algeria (3.1%), 259 in Morocco (2.6%) and
373 in Tunisia (3.1%).
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Table 2. Characteristics of adult subjects with asthma identiﬁed in the survey.
Algeria (N = 154) Morocco (N = 236) Tunisia (N = 234)
Age
Mean±SD 40.3±17.1 6.5±16.8 44.3±20.3
Median [Range] 39 [16 90] 32 [16 80] 42 [16 100]
Gender
Women 88 (57.1%) 142 (60.2%) 140 (59.8%)
Men 66 (42.9%) 94 (39.8%) 94 (40.2%)
Number of household members (mean±SD) 4.9 (± 2.1) 4.3 (± 1.7) 3.8 (± 1.8)
Smoking status
Active smoker 6 (4.0%) 10 (4.4%) 27 (12.2%)
Ex-smoker 21 (14.1%) 17 (7.5%) 44 (19.9%)
Passive smoker* 51 (34.2%) 62 (32.3%) 111 (50.5%)
Health status
Excellent 9 (5.9%) 10 (4.3%) 10 (4.3%)
Very good 12 (7.8%) 11 (4.8%) 10 (4.3%)
Good 38 (24.8%) 78 (33.9%) 61 (26.1%)
Average 61 (39.9%) 117 (50.9%) 122 (52.1%)
Poor 25 (16.3%) 9 (3.9%) 18 (7.7%)
Very poor 8 (5.2%) 5 (2.2%) 13 (5.6%)
Other comorbidities
Diabetes 13 (8.4%) 10 (4.2%) 19 (8.1%)
Hypertension 19 (12.3%) 13 (5.5%) 53 (22.6%)
Others 20 (13.0%) 31 (13.1%) 28 (12.0%)
*Another person smoking in the household.
Incidence of asthma (estimated)
Of the 624 adult subjects who provided data on the
duration of their asthma, 47 (7.5%) reported having
received a diagnosis within the previous twelve months. By
extrapolation to all patients fulﬁlling criteria for asthma
in the screening questionnaire, annual incidence rates
for asthma were estimated to be 46 [95%CI: 33 59]
cases/10 000 for Algeria, 43 [30 55] cases/10 000 for
Morocco and 28 [18 39] cases/10 000 for Tunisia.
Characteristics of subjects with asthma
The characteristics of the adult subjects with asthma
identiﬁed in the survey who completed the asthma
questionnaire are presented in Table 2. The equivalent
information for the paediatric population is provided in an
accompanying paper 30. The mean age of the subjects with
asthma ranged from 36.5 years in Morocco to 44.3 years in
Tunisia. Women were over-represented compared to men
by a factor of around 1.5. Exposure to tobacco smoke was
higher in Tunisia than in the other two countries. Overall,
38.7% of subjects stated that they were in good, very
good or excellent health. The most frequently cited treated
comorbidities were arterial hypertension (85 subjects;
13.6%) and diabetes (42 subjects; 6.7%).
Asthma features
Asthma history is presented in Table 3. The time since
diagnosis of asthma was very variable, and was over ten
years for most subjects. The initial presenting symptoms
were breathlessness (39.9% of subjects, particularly in
Tunisia) and chest tightness (35.5%, particularly in Algeria
and Morocco). The diagnosis was made as often by a general
practitioner as by a specialist, except in Morocco, where it
was made by a specialist in two-thirds of cases. It should
be noted that 41 patients overall (6.8%) were diagnosed
during a visit to the emergency department of a hospital.
The majority of subjects considered their asthma to have
improved since diagnosis, although 336 overall (54.7%) had
experienced a severe attack in the previous year.
Impact of asthma
A series of questions collected information on the impact
of asthma attacks on subjects’ lives in the previous year.
Around three-quarters of subjects overall (74.3%) reported
being handicapped by their asthma all or most of the time
(Fig. 4). Around one-quarter of respondents reported at
least one visit to a hospital emergency department in the
previous year and a similar proportion reported at least
one day’s absence from work or school due to asthma
(Table 4). The proportion of subjects who reported being
very or quite limited by their asthma with respect to
sport and leisure, normal physical activity, professional
activities, social activities, lifestyle and household tasks
ranged between one-third and one-half, according to the
item (Table 4). In addition, 48.0% reported that their sleep
was very or quite disturbed by asthma.
Discussion
The overall prevalence of asthma in the general population
of the Maghreb countries participating in this survey
was estimated to be 3.6%, with no relevant difference
apparent between the three countries. This corresponds to
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Table 3. Asthma history
Algeria (N = 154) Morocco (N = 236) Tunisia (N = 234)
Time since diagnosis
Mean±SD 14.1±11.9 14.5±11.9 13.8±13.4
Median [Range] 11 [0 60] 13 [0 72] 10 [0 70]
Diagnosis provided by:
General practitioner 64 (42.7%) 59 (26.1%) 96 (41.6%)
Specialist 62 (41.3%) 143 (63.3%) 114 (49.4%)
Emergency room 10 (6.7%) 19 (8.4%) 12 (5.2%)
Presenting symptoms*
Breathlessness 49 (31.8%) 85 (37.1%) 196 (84.9%)
Chest tightness 75 (48.7%) 145 (63.3%) 85 (36.8%)
Persistent cough 57 (37.0%) 122 (53.3%) 92 (39.9%)
Cold stress dyspnoea 61 (39.6%) 121 (52.8%) 64 (27.7%)
Wheezing 34 (22.1%) 87 (38.0%) 70 (30.3%)
Seasonality 89 (58.2%) 152 (66.7%) 156 (67.5%)
Evolution since diagnosis
Improvement 74 (48.4%) 163 (71.2%) 138 (59.5%)
No change 52 (34%) 43 (18.8%) 66 (28.4%)
Deterioration 27 (17.6%) 23 (10%) 28 (12.1%)
Severe attack in past year 105 (68.6%) 123 (53.7%) 108 (46.6%)
*Replies are not mutually exclusive; only replies cited by >15% of respondents overall are reported.
A severe attack was deﬁned as a severe bout of coughing, breathlessness, chest tightness or
wheezing.
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Fig. 4. Handicap due to asthma. Data are presented as the percentage of respondents. No respondent in any country replied ‘Never’.
a moderate prevalence rate from a worldwide perspective,
consistent with the rating of these countries in the most
recent GINA burden of asthma report 1. However, the large
scale of the AIRMAG project, its nationwide scope and its
use of the AIR methodology, previously used in reference
studies of the epidemiology of asthma in other countries,
strongly increases the conﬁdence with which such a rating
can be assigned.
Countrywide prevalence rates for paediatric asthma
in the three Maghreb countries ranged from 3.54% to
4.41%. These are lower than the most recent single-
centre prevalence estimates determined in the 1990s 22.
This difference may be due, at least in part, to the fact
that the latter studies were all performed in relatively
urbanised areas. A higher prevalence of asthma in urban
areas compared to rural areas was observed for children
in the ISAAC III study 31, and also in the AIRMAG study,
at least for the overall population. Concerning adults,
the prevalence rates observed are higher than those
observed in previous studies in Algeria, although it should
be pointed out that the latter are relatively old, did
not cover the whole country and, in some cases, did
not use representative sampling methods 24. In general,
prevalence rates for asthma in both children and adults
Prevalence of asthma in North Africa: the Asthma Insights and Reality in the Maghreb (AIRMAG) study S9
Table 4. Asthma impact
Algeria (N = 154) Morocco (N = 236) Tunisia (N = 234)
Hospitalisations
At least one 21 (13.7%) 20 (8.7%) 33 (14.2%)
Mean number±SD* 6.8±10.2 3.2±4.2 5.7±6.7
Emergency room visits
At least one 58 (37.9%) 48 (21.0%) 59 (25.4%)
Mean number±SD* 6.3±9.8 3.2±3.9 3.8±5.3
Family doctor call-outs
At least one 132 (93.0%) 171 (85.9%) 183 (80.3%)
Mean number±SD* 6.5±10.4 3.2±3.3 3.9±6.0
Absenteeism
At least one 34 (22.2%) 69 (30.3%) 46 (19.8%)
Mean number±SD* 19.6±22.9 10.3±13.6 13.8±21.4
Causes limitations in†:
Sport and leisure N = 60
30 (50.0%)
N = 167
78 (46.7%)
N = 93
43 (46.2%)
Normal physical activity N = 66
27 (40.9%)
N = 175
81 (46.3%)
N = 154
70 (45.5%)
Professional activities N = 62
22 (35.5%)
N = 113
58 (51.3%)
N = 97
32 (33.0%)
Social activities N = 69
25 (36.2%)
N = 134
52 (38.8%)
N = 109
37 (33.9%)
Sleep N = 142
68 (47.9%)
N = 203
81 (39.9%)
N = 226
125 (55.3%)
Lifestyle N = 142
50 (35.2%)
N = 171
67 (39.2%)
N = 222
108 (48.6%)
Household tasks N = 123
54 (43.9%)
N = 130
63 (48.5%)
N = 151
85 (56.3%)
*Calculated for subjects with at least one event.
†Data represent the number (%) of subjects providing information on the given item (N) who replied
‘very limited’ or ‘quite limited’ on a ﬁve-point Likert scale.
were quite similar across the three Maghreb countries,
probably reﬂecting similar exposure to environmental and
lifestyle risk factors.
As in the ECRHS 32 and ISAAC 4, we observed a higher
prevalence of asthma in female subjects then in males.
However, this difference was not consistent between
countries, being greatest in Morocco but not observable
in Algeria. The pattern of age-speciﬁc prevalence rates
exhibited a U-shaped curve, with highest rates in children
and the >54 year age group. However, these age differences
were more marked in Algeria than in Morocco. For
both age and gender, the pattern observed in Tunisia
was intermediate between those observed in Algeria and
Morocco. Since asthma prevalence before puberty is higher
in boys than in girls, whereas the reverse is true in adults 33,
these differences could arise from differences in the age
pyramids between the three countries.
Important regional variations in asthma prevalence were
observed in all countries. Generally speaking, prevalence
was highest in the more urbanised coastal plains than
in the more sparsely-populated mountainous and desert
regions. An exception to this trend was the unexpectedly
high prevalence rate observed in the Southern desert part
of Morocco. However, it should be noted that conﬁdence
intervals for the prevalence rate were wide in this region,
due to the low number of respondents (257 subjects overall,
15 with asthma). These ﬁndings are consistent with previous
observations on the prevalence of asthma in Africa 34, and
may reﬂect an increased risk of asthma associated with
urbanisation 20.
Annual incidence rates for asthma ranged between 28 and
46 cases per 10,000 subjects. It should be noted that these
overall incidence rates may conceal marked differences
in incidence related to age and gender, as has previously
been reported in the ECRH survey 32. Given the relatively
low number of incident cases in our sample, this level
of detail is not feasible in the AIRMAG population. The
incidence of asthma appeared somewhat lower in Tunisia
than in the other two countries, which may reﬂect the lower
relative weight of children in the population structure of
this country.
From a functional standpoint, most subjects reported
that their asthma had a signiﬁcant impact on their lives.
Around three-quarters of subjects reported asthma-related
handicap all or most of the time, around half had visited an
emergency department due to asthma in the previous year
and around one quarter had been hospitalised or needed
time off work or school. These ﬁndings suggest that asthma
is poorly controlled in the Maghreb countries. The ﬁndings
of the AIRMAG survey with respect to asthma control,
management and treatment will be developed in another
article of this supplement 35.
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This study has several strengths and limitations. The
large sample size and the nationwide sampling are clear
strengths of the study, as is the relatively high response
rate (65% globally and reaching 75% in Tunisia) compared to
random population-based studies in Europe. The use of the
AIR survey methodology is another strength of the study,
since this has now been used widely and been validated
in many parts of the world, which will allow the results
of the AIRMAG study to be compared with data collected
elsewhere.
With respect to limitations, the method of data collection
by questionnaire-based interviews in the home, limits
the precision of the medical data collected, notably
with respect to diagnosis, medication use and healthcare
resource consumption. Clearly, case ascertainment is
not possible in this type of general population study.
Nonetheless, over 95% of respondents reported having
received a diagnosis of asthma from a physician. Secondly,
the relatively low participation rate in Algeria (63%) is
of concern, although the consistency of the prevalence
results between the three countries would argue against
any major bias being introduced hereby. Overall response
rates are not inconsistent with those generally reported in
general population surveys in Europe and North America.
The fact that the survey was performed around the time of
elections in Algeria may have inﬂuenced the participation
rate. Thirdly, there may be a sampling bias due to
incomplete telephone coverage, with certain groups, for
example older people or those in very rural areas, not
having telephones. Fixed telephone coverage ranges from
51% of households in Morocco to 57% in Algeria, and the
proportion of individuals with mobile telephones ranges
from 64% in Morocco to 81% in Algeria. Finally, it is possible
that individuals with health problems may have been more
motivated to participate in the survey, which could lead to
an overestimate of prevalence rates.
In conclusion, the AIRMAG survey has shown that the
prevalence of asthma in the Maghreb countries is moderate,
but its impact is high.
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